T. Rowe Price Investment Management, Inc. Rx Sight, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 76,033 shares of RXST stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,033
Previous 189,027
59.78%
Holding current value
$2.89 Million
Previous $11.4 Million
66.95%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RXST
# of Institutions
225Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$149 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$91.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$87 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$66.4 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$44.5 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.05B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...